Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity

BPTSDelisted Stock  USD 7.03  0.00  0.00%   
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
  
IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA ACCESSWIRE April 18, 2024 Biophytis SA , ,

Read at accesswire.com
news
  

Biophytis Fundamental Analysis

We analyze Biophytis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Biophytis is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Biophytis Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biophytis stock to make a market-neutral strategy. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics with similar companies.

Peers

Biophytis Related Equities

AKTXAkari Therapeutics   1.00   
0%
8.0%
CHRSCoherus BioSciences   0.62   
0%
5.0%
INBXInhibrx   0.27   
0%
2.0%
RZLTRezolute   0.20   
1.0%
0%
XOMAOXOMA   0.39   
3.0%
0%
ARMPArmata Pharmaceuticals   0.45   
3.0%
0%
SPROSpero Therapeutics   0.86   
7.0%
0%
PCSAProcessa Pharmaceuticals   1.50   
12.0%
0%
ELYMEliem Therapeutics   1.90   
15.0%
0%
BOLTBolt Biotherapeutics   2.37   
19.0%
0%
NRXPNRX Pharmaceuticals   2.48   
20.0%
0%
HCWBHCW Biologics   2.55   
21.0%
0%
IPHAInnate Pharma   5.00   
41.0%
0%
TPSTTempest Therapeutics   5.06   
41.0%
0%
PTIXProtagenic Therapeutics   5.42   
44.0%
0%
ANEBAnebulo Pharmaceuticals   12.10   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Biophytis Stock

If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals